ID: ALA3084717

Max Phase: Preclinical

Molecular Formula: C13H17NO2S

Molecular Weight: 251.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1cccs1)C2

Standard InChI:  InChI=1S/C13H17NO2S/c1-14-9-4-5-10(14)8-11(7-9)16-13(15)12-3-2-6-17-12/h2-3,6,9-11H,4-5,7-8H2,1H3/t9-,10+,11+

Standard InChI Key:  JDLRSQVASPMBKN-URLYPYJESA-N

Associated Targets(non-human)

Glycine receptor subunit alpha-1 65 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 251.35Molecular Weight (Monoisotopic): 251.0980AlogP: 2.53#Rotatable Bonds: 2
Polar Surface Area: 29.54Molecular Species: BASEHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.28CX LogP: 2.44CX LogD: 0.56
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.76Np Likeness Score: -0.30

References

1. Maksay G, Vincze Z, Nemes P..  (2009)  Synthesis of heteroaromatic tropeines and heterogeneous binding to glycine receptors.,  17  (19): [PMID:19726200] [10.1016/j.bmc.2009.08.029]

Source